Rhenman & Partners Asset Management Ab has filed its 13F form on May 14, 2024 for Q1 2024 where it was disclosed a total value porftolio of $1.02 Billion distributed in 84 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cigna Corp with a value of $49.8M, Eli Lilly & CO with a value of $42.1M, Tenet Healthcare Corp with a value of $39.9M, Boston Scientific Corp with a value of $39.9M, and Elevance Health, Inc. with a value of $36M.

Examining the 13F form we can see an increase of $23M in the current position value, from $999M to 1.02B.

Rhenman & Partners Asset Management Ab is based out at Stockholm, V7

Below you can find more details about Rhenman & Partners Asset Management Ab portfolio as well as his latest detailed transactions.

Portfolio value $1.02 Billion
Healthcare: $1.02 Billion
Basic Materials: $4.37 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 84
  • Current Value $1.02 Billion
  • Prior Value $999 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 14, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 11 stocks
  • Additional Purchases 30 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 41 stocks
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.